| Literature DB >> 22443485 |
Tong Shen1, Shixia Xu, Xiaohong Wang, Wenhua Yu, Kaiya Zhou, Guang Yang.
Abstract
BACKGROUND: Cetaceans (whales, dolphins and porpoises) are a group of adapted marine mammals with an enigmatic history of transition from terrestrial to full aquatic habitat and rapid radiation in waters around the world. Throughout this evolution, the pathogen stress-response proteins must have faced challenges from the dramatic change of environmental pathogens in the completely different ecological niches cetaceans occupied. For this reason, cetaceans could be one of the most ideal candidate taxa for studying evolutionary process and associated driving mechanism of vertebrate innate immune systems such as Toll-like receptors (TLRs), which are located at the direct interface between the host and the microbial environment, act at the first line in recognizing specific conserved components of microorganisms, and translate them rapidly into a defense reaction.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22443485 PMCID: PMC3384459 DOI: 10.1186/1471-2148-12-39
Source DB: PubMed Journal: BMC Evol Biol ISSN: 1471-2148 Impact factor: 3.260
Figure 1Positive selection at TLR4 across the cetacean phylogeny. Branches a to p correspond to those in supplementary Table S2. The ω value calculated by the free-ratio model is labeled along each branch. In some cases, zero synonymous substitutions lead to a ω value of infinity (n.a.). The estimated numbers of nonsynonymous and synonymous changes are shown in parentheses. The branches in red show strong evidence of undergoing positive selection. Amino acid changes were estimated by parsimony method, and every substitution of these sites is marked in blue. Six clades in which amino acid substitution occurred are filled with six different colors. The parallel amino acid changes are listed on the right of the corresponding terminal branches, while b, c, h, and l in parentheses stand for the internal branches on which parallel changes occurred. Amino acid positions (numbers) and parallel changes at each position were listed in the right part of the figure1. A = even-toed ungulates, B = river dolphins, C = oceanic dolphins, D = porpoises and white whales, E = sperm whales, F = baleen whales.
Tests for positive selection at cetacean TLR4 using branch model and site models
| Model | Models Compared | -2lnΔL | df | Proportion of Sites under Selection | ω ( | |
|---|---|---|---|---|---|---|
| Site model | M1 versus M2 | 16.10 | 2 | < 0.0001 | 0.033 | 3.45 |
| M7 versus M8 | 16.48 | 2 | < 0.0001 | 0.033 | 3.55 | |
| M8a versus M8 | 16.10 | 1 | < 0.0001 | |||
| Branch model | M0 versus full | 44.13 | 31 | 0.0595 | ||
Positive selection at amino acid sites of cetacean TLR4
| PAML Site Model (M8) | FELd | RELd BF > 50 | AA Changes | Parallel Changes | Protein Domain | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 25 | Ser-Arg | Yes | SM, P, NEU-P.POS | LRR3 | B, C | |||||
| 28 | 0.07 | Leu-Trp | NP, NEU-P, NEU | LRR3 | A, D | |||||
| Leu-Pro | NP, NEU-SM, NP, NEU | |||||||||
| 45 | 0.16 | Thr-Ile | Yes | SM, P, NEU-NP, NEU | LRR4 | A, F | ||||
| 104 | 0.17 | Leu-Val | NP, NEU-NP, NEU | LRR6 | ||||||
| Leu-Ser | NP, NEU-SM, P, NEU | |||||||||
| 128 | 0.875 | Glu-Pro | P, NEG-SM, NP, NEU | LRR7 | D | |||||
| 133 | 0.723 | Asn-Lys | SM, P, NEU-P, POS | LRR7 | G | |||||
| 139 | 0.708 | Gly-Glu | SM, NP, NEU-P, NEG | LRR8 | Adjacent to site involved in interaction with MD2 | G | ||||
| 149 | 0.565 | Ser/Leu -Thr | SM, P, NEU/NP, NEU -SM, P, NEU | LRR8 | G | |||||
| 0.995 | 228.23 | His-Arg | Yes | P, POS-P, POS | LRR8 | A, B, C | ||||
| His-Asp | P, POS-SM, P, NEG | |||||||||
| 177 | 61.94 | Asn-Thr | SM, P, NEU-SM, P, NEU | LRR9 | Adjacent to site involved in ligand binding and interaction with MD2 | A, C, G | ||||
| 0.992 | 0.07 | 647.96 | Lys-Glu | Yes | P, POS-P, NEG | LRR9 | A, C, F | |||
| 0.12 | 51.06 | Arg-Ser | P, POS-SM, P, NEU | LRR9 | C, D | |||||
| 204 | Glu-His | Yes | P, NEG-P, POS | LRR10 | A, D | |||||
| 1.000 | 0.08 | 1563.58 | Gly/Lys | SM, NP, NEU/P, POS | LRR10 | A, G, C, E | ||||
| 212 | Leu-Val | Yes | P, POS-NP, NEU | LRR10 | A, B | |||||
| 221 | 0.1 | Val-Met | Yes | NP, NEU-NP, NEU | LRR11 | C, D, F | ||||
| 0.994 | 0.15 | 544.88 | Asp/Ser/Cys | SM, P, NEG/SM, P, NEU/SM, NP, NEU | LRR11 | A, G | ||||
| 230 | 0.978 | Gly/Glu/Asp | SM, NP, NEU/P, NEG/SM, P, NEG | LRR11 | A, E | |||||
| 239 | 50.32 | Cys-Tyr | Yes | SM, NP, NEU-P, NEU | LRR12 | B, D, G | ||||
| 0.14 | 86.14 | Ile-Thr | NP, NEU-SM, P, NEU | LRR12 | Adjacent to site involved in interaction with ligand binding | C, G | ||||
| 0.936 | Asp/Ala | SM, P, NEG/SM, NP, NEU | LRR12 | Ligand binding | A, E, G | |||||
| 265 | Phe-Leu | Yes | NP, NEU-NP, NEU | LRR13 | B, E | |||||
| 0.997 | 0.13 | 188.28 | Gly/Asp- | SM, NP, NEU/SM, P, NEG-P, POS | LRR13 | Adjacent to site involved in interaction with ligand binding | A, C | |||
| 0.952 | 0.18 | 191.07 | Glu-Ala | Yes | P, NEG-SM, NP, NEU | LRR13 | A, B, E | |||
| 302 | 0.624 | His-Arg | P, POS-P.POS | LRR14 | D | |||||
| 304 | 55.05 | Asp-Asn | SM, P, NEG-SM, P, NEU | LRR14 | G | |||||
| 0.996 | 301.87 | Asn-Ser | SM, P, NEU-SM, P, NEU | LRR15 | Adjacent to site involved in interaction with ligand binding (hydrogen bond) | C, E, G | ||||
| 342 | 53.56 | Asn-Ser | SM, P, NEU-SM, P, NEU | LRR16 | Adjacent to site involved in interaction with ligand binding (hydrogen bond) | A | ||||
| 351 | 0.17 | Ile/Ala-Val | NP, NEU/SM, NP, NEU-NP, NEU | LRR16 | Adjacent to site involved in interaction with ligand binding (hydrophobic interaction) | G | ||||
| 368 | 0.576 | Ile-Thr | NP, NEU-SM, P, NEU | LRR17 | Adjacent to site involved in interaction with ligand binding (hydrophobic interaction) | G | ||||
| 404 | 0.08 | Leu-Met | NP, NEU-NP, NEU | LRR18 | C | |||||
| 408 | Ile-Thr | Yes | NP, NEU-SM, P, NEU | LRR19 | A, G | |||||
| 409 | 0.19 | Leu/Ile/Phe | NP, NEU/NP, NEU/NP, NEU | LRR19 | A | |||||
| 482 | 0.16 | Ser/Trp- | SM, P, NEU/P, NEU-NP, NEU | LRR22 | A | |||||
| 542 | 0.903 | Met-Thr | Yes | NP, NEU-SM, P, NEU | LRRCT | A, D | ||||
| 551 | 0.938 | Ile-Val | Yes | NP, NEU-NP, NEU | Transmembrane | B, F | ||||
| 559 | 0.16 | Val-Ala | NP, NEU-SM, NP, NEU | Transmembrane | G | |||||
| 690 | 0.564 | Arg-Gln | P, POS-P, NEU | TIR | D | |||||
| 740 | 0.790 | Glu-Asp | P, NEG-SM, P, NEG | TIR | G | |||||
| 742 | 0.697 | Asn-Arg | SM, P, NEU-P, POS | TIR | G | |||||
| 743 | 0.18 | Gln-Glu | P, NEU-P, NEG | TIR | A, F |
a Codons identified by more than one ML method were in bold and underlined.
b Site 250 in italic was mapped onto the 3D structure of TLR4, since it directly participates in binding of LPS to TLR4.
c Codons were identified by branch-site model in PAML. Details were in Materials and Methods and Additional file 2: Table S2.
d Codons were estimated in DATAMONKEY.
e SM, small; NP, nonpolar; P, polar; NEU, neutral; POS, positively charged; NEG, negatively charged.
f Codons were in the functional regions predicted by the three-dimensional structure in Shishido et al. 2010. LRR = Leucine-rich repeat, CT = C-terminal, TIR = cytoplasmic Toll/IL-1 receptor
g Amino acid substitutions occurred in the following clades: A = even-toed ungulates, B = river dolphins, C = oceanic dolpins, D = porpoises and white whales, E = sperm whales, F = baleen whales, G = more than one equally parsimonious reconstruction
35]. Of these positively selected codons identified using the branch-site model, sites 139 (p = 0.708) in branch a (whale + hippo) and 128 (p = 0.875) in branch d (beluga whale) (Figure 1) showed a stronger signature, with radical amino acid changes in size, polarity, and electric charge (Table 2), and fell in the functionally important region of TLR4 as suggested by Shishido et al. [36].
Figure 2Average ω ratio of a 20-codon sliding window along cetacean TLR4 protein sequences. High values (ω > 1) indicate positive selection, whereas low values (ω < 1) indicate purifying selection. The black box indicates the transmembrane domain.
Figure 3Distribution of positively selected codons in the three-dimensional structure of cetacean TLR4. The area important for ligand binding is squared in pink.